← Leaderboards
William C Mobley
University Of California, San Diego
$20,695,689
Attributed
$24,831,500
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12M · FY2005–24$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$37,296,408 · 16
By mechanism
R01$20,736,472 · 8
U19$11,492,955 · 1
R61$1,698,323 · 1
P01$1,470,459 · 1
P30$971,953 · 1
K12$885,427 · 1
Top collaborators
- Eugene Yu5 shared
- Michael S Rafii1 shared
- Michael G Rosenfeld1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Stephanie Cherqui$8,679,209
- Alysson R. Muotri$33,814,580
- Steven Lee Wagner$8,475,404
- Kevin D Rynearson$1,261,015
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsS DiseasePhenotypeGenesStructureNerve DegenerationProteinsDown SyndromePreventGene ExpressionSignal TransductionBaseCognitionLinkIn VitroMouse ModelTrisomySynapsesMutantNeurotrophic FactorNeuropathologyMediatingDementia
Grant awards (54)
Develop and Validate a Mouse Model for Alzheimer Disease in Down Syndrome$1,698,323
R61 · FY2024 · NS · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$642,516
R01 · FY2023 · AG · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$701,954
R01 · FY2022 · AG · contact PI
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$516,281
R01 · FY2022 · AG · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$270,276
R01 · FY2022 · AG · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$732,109
R01 · FY2021 · AG · contact PI
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$652,884
R01 · FY2021 · AG · contact PI
Multiplexed Single Nucleus RNA and ATAC-seq Sequencing and Cortical Organoids: Transformative Insights into Down Syndrome$5,047,008
R01 · FY2020 · AG
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$647,470
R01 · FY2020 · AG · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$567,567
R01 · FY2020 · AG · contact PI
Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro$230,286
P01 · FY2020 · NS · contact PI
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$602,811
R01 · FY2019 · AG · contact PI
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease$463,515
R01 · FY2019 · AG · contact PI
Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro$303,974
P01 · FY2019 · NS · contact PI
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$499,198
R01 · FY2018 · AG · contact PI
Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro$304,528
P01 · FY2018 · NS · contact PI
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease$253,254
R01 · FY2018 · AG · contact PI
Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro$315,480
P01 · FY2017 · NS · contact PI
Project 2: The impact of TRiC reagents on mHTT-induced neuronal degeneration in vitro$316,191
P01 · FY2016 · NS · contact PI
Alzheimer's Disease Cooperative Study$11,393,316
U19 · FY2015 · AG · contact PI
University of California, San Diego Neuroscience Microscopy Imaging Core$500,102
P30 · FY2015 · NS · contact PI
Alzheimer's Disease Cooperative Study$99,639
U19 · FY2015 · AG · contact PI
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21$639,107
R01 · FY2014 · NS · contact PI
University of California, San Diego Neuroscience Microscopy Imaging Core$471,851
P30 · FY2014 · NS · contact PI
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21$622,979
R01 · FY2013 · NS · contact PI
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21$645,513
R01 · FY2012 · NS · contact PI
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21$645,534
R01 · FY2011 · NS · contact PI
NEURONAL AXONS (AXONS FROM DRG NEURONS)$7,369
P41 · FY2011 · RR · contact PI
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21$671,481
R01 · FY2010 · NS · contact PI
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome$518,723
R01 · FY2010 · NS · contact PI
NEURONAL AXONS (AXONS FROM DRG NEURONS)$6,450
P41 · FY2010 · RR · contact PI
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome$316,632
R01 · FY2009 · NS · contact PI
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome$102,034
R01 · FY2009 · NS · contact PI
2009 Neurotrophic Factors Gordon Research Conference$27,000
R13 · FY2009 · NS · contact PI
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome$369,547
R01 · FY2008 · NS · contact PI
Nerve Growth Factor-Mechanisms for Signal Transduction$315,974
R01 · FY2008 · NS · contact PI
Nerve Growth Factor-Mechanisms for Signal Transduction$315,974
R01 · FY2007 · NS · contact PI
Disrupted Transport of NGF-TrKA Signaling in Mouse Models of Down Syndrome$304,941
R01 · FY2007 · NS · contact PI
Training in Translational Develomental Neuroscience$284,580
K12 · FY2007 · NS · contact PI
Nerve Growth Factor-Mechanisms for Signal Transduction$325,411
R01 · FY2006 · NS · contact PI
Training in Translational Develomental Neuroscience$157,777
K12 · FY2006 · NS · contact PI
Nerve Growth Factor-Mechanisms for Signal Transduction$333,405
R01 · FY2005 · NS
Training in Translational Develomental Neuroscience$284,580
K12 · FY2005 · NS
Nerve Growth Factor-Mechanisms for Signal Transduction$333,243
R01 · FY2004 · NS
Training in Translational Develomental Neuroscience$158,490
K12 · FY2004 · NS
MAPPING DS RELATED CNS PHENOTYPES$515,525
R01 · FY2002 · NS
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION$326,211
R01 · FY2002 · AG
MAPPING DS RELATED CNS PHENOTYPES$501,990
R01 · FY2001 · NS
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION$318,882
R01 · FY2001 · AG
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION$157,000
R01 · FY2001 · AG
MAPPING DS RELATED CNS PHENOTYPES$427,253
R01 · FY2000 · NS
NGF SIGNALING IN MODELS OF AGE RELATED NEURODEGENERATION$311,762
R01 · FY2000 · AG
MAPPING DS RELATED CNS PHENOTYPES$70,508
R01 · FY2000 · NS
MAPPING DS RELATED CNS PHENOTYPES$50,000
R01 · FY2000 · NS